Leerink Partners Maintains Tenax Therapeutics(TENX.US) With Buy Rating, Maintains Target Price $16
Roth MKM Maintains Tenax Therapeutics(TENX.US) With Buy Rating, Maintains Target Price $30
Roth MKM Sticks to Their Buy Rating for Tenax Therapeutics (TENX)
Leerink Partners Initiates Tenax Therapeutics(TENX.US) With Buy Rating, Announces Target Price $16
Tenax Therapeutics Price Target Announced at $16.00/Share by Leerink Partners
Guggenheim Initiates Tenax Therapeutics(TENX.US) With Buy Rating, Announces Target Price $16
Tenax Therapeutics Analyst Ratings
William Blair Initiates Tenax Therapeutics(TENX.US) With Buy Rating
Tenax Therapeutics Analyst Ratings
Roth MKM Reiterates Buy on Tenax Therapeutics, Maintains $6 Price Target
Tenax Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Tenax Therapeutics (TENX) and Day One Biopharmaceuticals (DAWN)
Roth MKM Initiates Coverage On Tenax Therapeutics With Buy Rating, Announces Price Target of $6
Tenax Therapeutics (TENX) Receives a Buy From H.C. Wainwright
H.C. Wainwright Sticks to Their Buy Rating for Tenax Therapeutics (TENX)